Genmab — November 2015
-
spændende om Royalty i december alene bliver højere end arzeras 20 millioner. Jeg kunne godt tro det
-
haha no way McJean
-
50 millioner $ i decemember og 6 mio. $ i royalty til genmab vil være en drøm
-
Hver behandlingscyklus på 28 dage indebærer 4 infusioner https://www.clinicaltrials.gov/ct2/show/study/NCT02477891?term=daratumumab&rank=16&show_locs=Y#locn Hvis vi antager jkj's pris pr infusion og 12000 patienter bliver det 280 mio $ om måneden.
-
-
DARZALEX® (daratumumab) Approved by U.S. FDA: First Human Anti-CD38 Monoclonal Antibody Available for the Treatment of Multiple Myeloma
First-in-class immunotherapy approved for multiple myeloma patients who have received three or more prior lines of therapy, including a proteasome inhibitor (PI) and an immunomodulatory agent or who are double refractory to a PI and immunomodulatory agent
Multivu (www.multivu.com)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind